Compare INTS & GTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTS | GTEC |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | N/A | 340 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 13.4M |
| IPO Year | 2021 | N/A |
| Metric | INTS | GTEC |
|---|---|---|
| Price | $5.00 | $0.57 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $38.00 | N/A |
| AVG Volume (30 Days) | 28.0K | ★ 89.5K |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.62 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.19 | $0.56 |
| 52 Week High | $8.06 | $2.47 |
| Indicator | INTS | GTEC |
|---|---|---|
| Relative Strength Index (RSI) | 36.79 | 29.04 |
| Support Level | $0.29 | N/A |
| Resistance Level | $8.06 | $0.80 |
| Average True Range (ATR) | 0.20 | 0.04 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 4.76 | 39.82 |
Intensity Therapeutics Inc . is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.